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Metal-on-metal (MoM) total hip arthroplasties (THAs) are associated with high rates of failure due to the release of cobalt and chromium from the bearing surface and/or the femoral headstem taper junction. [1] [2] [3] [4] [5] [6] There is now evidence to suggest that similar problems can also occur in patients without MoM bearing surfaces. 7 Worldwide authorities recommend that patients with a MoM THA undergo regular surveillance to detect complications early. [8] [9] [10] The Pinnacle system (DePuy Synthes, Leeds, United Kingdom) was one of the most commonly used MoM THA devices, with approximately 180 000 having been undertaken worldwide. 3, [11] [12] [13] High rates of revision have been reported for MoM THAs which involve Pinnacle acetabular components in registries 3,11 and large singlecentre studies. 12, [14] [15] [16] [17] Two recent studies, 12, 17 together involving more than 1000 primary 36 mm MoM Pinnacle components (8.4% of all such implants within the National Joint Registry (NJR)), 11 Follow us @BoneJointJ THE BONE & JOINT JOURNAL both reported that those undertaken from 2006 onwards had a significantly increased risk of failure compared with those undertaken before this time. Analysis of explanted components also showed that Pinnacle components manufactured from 2006 onwards were increasingly likely to have lower clearance values than was intended by the manufacturer. 12 It has been postulated that these previously unrecognized changes in the manufacturing process may be responsible for the increased rates of failure reported from 2006 onwards. 12, 17 These observations are concerning and, if specific to Pinnacle MoM acetabular components, may require important changes to the surveillance of patients with these components. [8] [9] [10] Assessment of the effect of the year of primary surgery on revision rates in a large unselected group of patients would therefore be advisable. Although an initial review of Pinnacle MoM acetabular components recorded in the NJR did not show a higher rate of revision for the batch numbers identified previously compared with the others, 12 it was suggested that this analysis should be repeated. 18 The aim of this study was to validate the findings from the two recent cohorts of patients with Pinnacle MoM components using the NJR data and novel statistical methodology. 12, 17 We investigated whether the five-year revision rates for 36 mm MoM THAs with Pinnacle acetabular components, and for a control group of all other MoM THAs, were higher in primary THAs undertaken from 2007 onwards compared with those undertaken before this time. The year 2007 was chosen as this represented the first complete calendar year following the postulated changes in the clearance values of the Pinnacle MoM component.
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Patients and Methods
We performed a retrospective observational study using the NJR which has recorded all THAs performed in hospitals in England and Wales since April 2003.
11 Unique patient identifiers allow linkage of primary procedures to any subsequent revisions where components were removed or exchanged. The NJR obtains data on the time to death following arthroplasty from the Personal Demographics Service. Anonymized data were extracted from the NJR up to and including 31 December 2015. The data involved all primary 36 mm MoM THAs with a cementless Pinnacle acetabular component implanted with either a Corail (DePuy) (12/14 taper) or S-ROM (DePuy) (11/13 taper) cementless femoral component, the last recorded operation having taken place in August 2012. These two femoral components were those that were most commonly used with the Pinnacle MoM acetabular component and were selected as these designs have been previously studied. 12, 17 Both femoral components were made of titanium alloy and were implanted with an Ultamet cobalt-chrome alloy liner, and either an Ultamet (S-ROM) or Articul/eze (Corail) cobaltchrome alloy femoral head (all manufactured by DePuy). Further information about these components has been described. 12, 15, 19 The final 36mm Pinnacle MoM cohort for analysis included 11 826 THAs.
A control group of all other primary MoM THAs (≥ 36 mm) undertaken between 2003 and 2012 was extracted from the NJR (n = 14 934). This group included all designs apart from the Articular Surface Replacement (ASR) (DePuy) MoM THAs and MoM THAs with Pinnacle acetabular components. The control group therefore included a variety of manufacturer designs and femoral head sizes. The exposure of interest was the year of primary THA, which was grouped as described. The NJR collects data for all procedures including the demographics of the patents and the operation (age, gender, body mass index (BMI), American Society of Anesthesiologists (ASA) grade, 20 indication, the grade of the surgeon and the components used), which were adjusted for in our analysis.
The outcome of interest was all-cause revision including removal or exchange of any component. Surgeons can record one or many indications when performing revisions, including infection, periprosthetic fracture, aseptic loosening, dislocation/subluxation, adverse reactions to metal debris (ARMD) (which has been available since June 2008 but is specifically recorded in the NJR as adverse soft-tissue reaction to particulate debris), lysis, malalignment, wear, fracture of a component, mismatch between the femoral head and the acetabular component, dissociation of the liner, pain and other. Statistical analysis. All analyses were performed using Stata Version 13.1 (StataCorp, College Station, Texas), with a 5% level of significance and 95% confidence intervals (CI). Cumulative all-cause rates of revision following primary Pinnacle MoM THA were estimated using the Kaplan-Meier method. Those not undergoing revision were censored on the date of the end of the study (31 December 2015) , or at the time of death if earlier. Revision rates were determined for the whole cohort and also for a follow-up controlled cohort in the Pinnacle group only. This is subsequently referred to as the five-year cohort, which included all patients with the potential for at least five years follow-up, who hence by definition had their primary THA before 2011, with revision outcomes censored at five years from the date of the primary THA in those who had not undergone revision or died within this period (Table I) .
Univariable and multivariable Cox proportional hazards models were used to assess the effect of the year of the primary THA on the time to all-cause revision in both the whole cohort (for Pinnacle THAs) and the five-year cohort (for both Pinnacle and other MoM THAs). Proportional hazards assumptions were assessed using Schoenfeld's residuals and satisfied. Multivariable models were adjusted for age, gender, BMI, ASA grade, indication, the grade of the surgeon, the design of the femoral component and bilateral MoM THAs.
For the five-year cohort (for both Pinnacle and other MoM THAs), five-year all-cause rates of revision were cal-culated for each calendar year of primary implantation. The five-year rate of revision was calculated by dividing the total number of all-cause revisions by the total number of individual implant-years at risk in the five-year cohort, and was expressed as the number of all-cause revisions per 1000 implant-years at risk.
Interrupted time-series analysis (longitudinal quasiexperimental design) 21 Controlling for the baseline level and trend, the models estimate changes in levels and trends of rates after this time. The regression model includes terms to estimate the preexisting level for each rate in the first six months of the period of observation (intercept), the trend in the rate before the change in 2007, the change in level of the rate after 2007, and the change in trend after 2007. Regression diagnostics confirmed the underlying model assumptions and that there was no evidence of serial autocorrelation (Durban-Watson test) and seasonality. 22 
Results
For the whole Pinnacle cohort (n = 11 826), all-cause revision was performed in 1190 (10.1%) THAs at a mean of 4.6 years (0.003 to 11.1) postoperatively. The most common (Fig. 1) .
In the five-year Pinnacle cohort (n = 10 776), 627 THAs (5.8%) were revised for any indication at a mean of 2.7 years (0.003 to 4.99) postoperatively (Table I ). The most common indication was ARMD (31.6%) ( Table II) The five-year control group included 13 817 other MoM THAs (Table I) Trends in the five-year all-cause rates of revision for all metal-on-metal total hip arthroplasties with year of primary implantation. The five-year rate of revision has been expressed as the number of all-cause revisions per 1000 implant-years at risk.
performing revision in recent years. High revision rates for MoM THAs were first identified with ASR components leading to recall by the manufacturer and an alert from the Medical and Healthcare products Regulatory Agency (MHRA) in 2010. 1, 23 High revision rates were subsequently observed in other MoM THA designs. [2] [3] [4] 11 This led to another MHRA alert being issued in 2012, recommending that all patients with 36 mm or greater MoM THAs required a minimum of annual clinical surveillance, regardless of symptoms. 8 Some centres had routinely started investigating these patients earlier than 2012 12,14 because of problems reported with hip resurfacings. 24, 25 Furthermore, the poor short-term outcomes following revision of MoM THAs for ARMD 26, 27 led surgeons and regulatory authorities to recommend early revisions. [8] [9] [10] 26, 28 Surgeons subsequently adopted a lower threshold for performing revision surgery for ARMD in patients with a MoM THA, with evidence that this strategy can improve outcomes. 28, 29 It is important to recognize that as our study used a fiveyear follow-up, only revision rates in the 2007 onwards group would have significantly been influenced by the increased surveillance and lowering threshold for revision, which largely occurred around 2012 onwards. It is also worth acknowledging that although the 2007 timepoint was of a priori interest here, the data presented also show a general trend of increasing revision rates with the passage of time for all MoM THAs recorded in the NJR (Fig. 3) . Regular surveillance and lowering the threshold for revision are again likely to be responsible for this.
A recent systematic review showed that more intensive surveillance protocols including blood metal ions and cross-sectional imaging were associated with the highest prevalence of revision surgery for ARMD. 30 Given that most patients with a MoM THA will have undergone such intensive surveillance since 2012, 8 it would be expected that all those undertaken from 2007 onwards would have significantly higher five-year revision rates compared with those undertaken before this time that were not subjected to this follow-up. In addition to surveillance bias, the lowering of the threshold for performing revision has been implicated in the increasing rates of failure due to ARMD seen following MoM THA. 17, 31 A report on 1429 hip resurfacings recorded that those undertaken from 2007 onwards had a 2.4 times increased risk of revision for ARMD compared with those undertaken before this time. 31 The present NJR findings for all MoM THAs support recent observations about resurfacings.
Based on the current findings, no changes to surveillance protocols for patients with a MoM THA are recommended. [8] [9] [10] However, registries can under-report revisions 32, 33 and they do not contain data on the analysis of explanted components. Hence, if there truly was a widespread change in the Pinnacle manufacturing process that may have influenced revision rates, as suggested by the analysis of explants, 12 it may take time for this to be detected within the registry. Indeed, it took some time for registries to identify problems with recalled ASR THAs.
3,11
Furthermore, one study reported that the higher failure rates with more recent Pinnacle acetabular components only became apparent between four and eight years postoperatively. 17 This may not have been apparent in the present analysis because it was based on a cohort with a five-year follow-up. Therefore, the NJR analysis should be repeated in the future to establish whether or not rates of revision for Pinnacle MoM acetabular components undertaken from 2007 onwards have substantially increased relative to those of other MoM THAs.
The strengths of this study include the use of a large unselected cohort of MoM THAs, approximately 7% of all MoM THAs involving Pinnacle acetabular components undertaken worldwide, 12 which reduces the likelihood of sampling bias and increases the general applicability of the findings. The large cohort ensures statistical power when assessing revision rates in relation to the year of initial procedure. The NJR uses linked data to capture revisions performed at different institutions with almost complete compliance.
11 This study was also strengthened by having a large control group. Without this comparator group, the findings would have been incorrectly interpreted.
Limitations include the use of observational registry data, which means that we cannot infer causality. However, this work was undertaken specifically to assess whether the findings regarding the year of primary surgery and rates of failure were reproducible in a large cohort. A recent study of retrieved components reported that 23% of revisions performed were not recorded in the NJR. 32, 33 Therefore, our revision rates may be underestimated. The design of the femoral component was a potential confounding variable given that femoral components of different design were used with the Pinnacle MoM acetabular component at different times (supplementary material), and that the S-ROM has a higher revision rate than the Corail stem.
11 However, the design of the femoral component was controlled for in the multivariable models and did not change the findings. In line with worldwide usage, 2,3,11 small numbers of Pinnacle components were used in 2003 and from 2011 onwards, therefore revision rates for these years could not be meaningfully assessed. Although the revision rates have been reported per year of operation, this does not necessarily reflect the year of manufacture. This may be most relevant in centres where fewer MoM THAs were undertaken.
Interrupted time-series analysis generally requires at least eight preintervention and postintervention data points, 34 and at least 100 observations at each timepoint 35 to achieve an acceptable level of variability of the estimate at each timepoint. While the number of observations available at each timepoint was high, we were limited by the number of preintervention timepoints. As it was not known exactly when the potential changes in the clearance of the Pinnacle MoM acetabular component occurred in 2006, it is possible that some components with the new clearance were included in the pre-2007 group. This cutoff was chosen to ensure further power was not lost with the preintervention aspect of the time-series analysis. However, it is clear that excluding the 2006 data points would not have changed the findings and this was confirmed in a multivariable model excluding the 2006 Pinnacle MoM THAs. A fixed followup period of five years was chosen to reduce the bias when comparing rates of revision between the Pinnacle and control groups, with similar methods having been used previously. 17 However, it is recognized that the revision rates by year of operation in both the Kaplan-Meier and interrupted time-series analyses will have been influenced by the external time-dependent confounder of increased surveillance and lowering of the threshold for revision in recent years. This must be considered when interpreting our findings. It is also acknowledged that the control group was heterogeneous, including a variety of designs of MoM THA and sizes of femoral head, compared with the Pinnacle group. This was necessary in order to ensure adequate numbers for powering the study given the large size of the Pinnacle group. However, this is mitigated by all MoM THAs with femoral head size of ≥ 36 mm being treated differently after 2012, with increased surveillance and reduced thresholds for performing revision surgery. Finally, there is a potential for residual confounding in the analysis.
In conclusion, data from the world's largest arthroplasty registry has shown that five-year revision rates were significantly increased in all primary MoM THAs undertaken from 2007 onwards compared with those undertaken before this time. This finding was not specific to Pinnacle MoM acetabular components and therefore does not support concerns about potential changes in the Pinnacle manufacturing process and higher revision rates in more recent years. 12, 17 The observations in NJR data regarding the change in rates of revision for all MoM THAs with the passage of time may be explained by more intensive surveillance and a progressive lowering of the threshold for performing revision surgery.
Take home message:
-Five-year revision rates were significantly higher in all primary MoM THAs undertaken from 2007 onwards and not just in THAs involving Pinnacle acetabular components. -The study findings may be explained by more intensive surveillance and recent lowering of the threshold for performing revision.
Supplementary material
A table showing femoral component design implantation over time for the whole Pinnacle cohort is available alongside the online version of this article at www.bjj.boneandjoint.org.uk
